Company Comparison
DNA Script vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | DNA Script | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Paris, France | Lagos, Nigeria |
| Founded | 2014 | 2019 |
| Status | Active | Active |
| Last Funding Stage | Series B | Series B |
| Total Funding | $134M | $45M |
| Valuation | — | — |
What They Build
DNA Script
Biotechnology company developing enzymatic DNA synthesis technology to enable on-demand, decentralized production of synthetic DNA for research and therapeutics.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
DNA Script
Sector Overlap
Both DNA Script and 54gene operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.